Roswell Park Cancer Institute ( Site 0192), Buffalo
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0208), Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
at 2 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

New York Oncology Hematology, P.C. ( Site 0129), Albany
Icahn School of Medicine at Mount Sinai ( Site 0164), New York
New York Cancer and Blood Specialists ( Site 9000), Shirley

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06717347

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

New York University (NYU) Clinical Cancer Center, New York
Weill Cornell Medicine, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Columbia University, New York
University of Rochester, Rochester

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Memorial Sloan Kettering Cancer Center ( Site 1010), New York
New York Medical College ( Site 1023), Valhalla

Nagre-recruitPhase 1/2

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

New York Oncology Hematology, P.C., Albany
Hematology Oncology Associates of Central New York, East Syracuse

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05272384

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York
University of Rochester Medical Center, Rochester

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06500273

A Study of ARC-02 in B-cell NHL

NYU Langone, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Nagre-recruitPhase 1/2

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Roswell Park Comprehensive Cancer Center, Buffalo

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
at 1 pa

Nagre-recruitPhase 2

Edad 65 hanggang 80 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06765317

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Roswell Park Cancer Institute, Buffalo

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06863402

DALY II USA/ MB-CART2019.1 for DLBCL

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center - Moses Campus, The Bronx

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

New York Medical Center, Valhalla

Nagre-recruitPhase 1/2

Edad 12 hanggang 70 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04491370

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
at 1 pa

Nagre-recruitMaagang Phase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT04512716

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT05633615

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Columbia University, New York

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT06693830

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
at 1 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06736613

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Wilmot Cancer Institute, Rochester

Nagre-recruitPhase 2

Edad 70 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT06828991

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05890352

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Memorial Sloan Kettering Cancer Center (All protocol activities), New York
NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT05940272

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

New York Medical College, Valhalla

Nagre-recruitPhase 2

Edad 3 hanggang 31 · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT02393157

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 26, 2024 · NCT06238648

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.